Shorter vs. longer blood thinner therapy after stenting for high Lp(a)
Part of Heart & circulation clinical trials.
This trial compares 12 months versus 24 months of dual antiplatelet therapy (two blood thinners) after a stent placement in people with high lipoprotein(a) levels. It aims to see if longer treatment reduces heart risks without increasing bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have a high level of lipoprotein(a) (Lp(a) > 30 mg/dL) before your stent procedure
- You had a drug-eluting stent placed and have not had a heart attack, stroke, or major bleeding in the past year
- You are willing to take two blood thinners for up to 2 years and attend follow-up visits
- You do not have severe heart failure, kidney disease, or other serious health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is comparing two durations of antiplatelet therapy (blood thinners) after getting a heart stent, using ultrasound guidance to tailor the treatment. The goal is to find a shorter, safer medication plan that still prevents blood clots and heart attacks.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This trial is testing a way to shorten the time you need to take blood thinners after getting a specific type of heart stent. It uses a special camera (OCT) inside the artery to help decide if stents are placed well enough to allow less time on dual antiplatelet therapy.
This study compares taking blood-thinning medicine for 1 month versus 6 months after a balloon angioplasty to open a small heart artery. The goal is to find out which duration is safer and more effective for preventing future heart problems.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.